| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel pyrazole-containing indolizine derivative suppresses NF-κB activation and protects against TNBS-induced colitis via a PPAR-γ-dependent pathway
|
Fu, Yong
|
|
2017
|
135 |
C |
p. 126-138
|
artikel
|
| 2 |
Capadenoson, a clinically trialed partial adenosine A1 receptor agonist, can stimulate adenosine A2B receptor biased agonism
|
Baltos, Jo-Anne
|
|
2017
|
135 |
C |
p. 79-89
|
artikel
|
| 3 |
Discovery of a new Mycobacterium tuberculosis thymidylate synthase X inhibitor with a unique inhibition profile
|
Abu El Asrar, Rania
|
|
2017
|
135 |
C |
p. 69-78
|
artikel
|
| 4 |
Editorial Advisory Board
|
|
|
2017
|
135 |
C |
p. iii
|
artikel
|
| 5 |
Inhibition and inactivation of human CYP2J2: Implications in cardiac pathophysiology and opportunities in cancer therapy
|
Karkhanis, Aneesh
|
|
2017
|
135 |
C |
p. 12-21
|
artikel
|
| 6 |
Mechanisms of colitis-accelerated colon carcinogenesis and its prevention with the combination of aspirin and curcumin: Transcriptomic analysis using RNA-seq
|
Guo, Yue
|
|
2017
|
135 |
C |
p. 22-34
|
artikel
|
| 7 |
3-O-(Z)-coumaroyloleanolic acid overcomes Cks1b-induced chemoresistance in lung cancer by inhibiting Hsp90 and MEK pathways
|
Wang, He
|
|
2017
|
135 |
C |
p. 35-49
|
artikel
|
| 8 |
Potentiating SLC transporter activity: Emerging drug discovery opportunities
|
Rives, Marie-Laure
|
|
2017
|
135 |
C |
p. 1-11
|
artikel
|
| 9 |
Quantitation of the rates of hepatic and intestinal cholesterol synthesis in lysosomal acid lipase-deficient mice before and during treatment with ezetimibe
|
Chuang, Jen-Chieh
|
|
2017
|
135 |
C |
p. 116-125
|
artikel
|
| 10 |
Regulation of the nitric oxide oxidase activity of myeloperoxidase by pharmacological agents
|
Maiocchi, Sophie L.
|
|
2017
|
135 |
C |
p. 90-115
|
artikel
|
| 11 |
Reversal of cisplatin resistance in human gastric cancer cells by a wogonin-conjugated Pt(IV) prodrug via attenuating Casein Kinase 2-mediated Nuclear Factor-κB pathways
|
Chen, Feihong
|
|
2017
|
135 |
C |
p. 50-68
|
artikel
|
| 12 |
The pharmacokinetics and metabolism of lumiracoxib in chimeric humanized and murinized FRG mice
|
Dickie, A.P.
|
|
2017
|
135 |
C |
p. 139-150
|
artikel
|
Tijdschrift beschrijving